NewAmsterdam Pharma Stock Target Price and Analyst Consensus

NAMS Stock   23.87  0.20  0.83%   
The current analyst and expert consensus on NewAmsterdam Pharma is Strong Buy, with 5 strong buy opinions. The current projected NewAmsterdam Pharma target price consensus is 37.00 with 10 analyst opinions. Check out Macroaxis Advice on NewAmsterdam Pharma to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For more information on how to buy NewAmsterdam Stock please use our How to Invest in NewAmsterdam Pharma guide.
The most common way NewAmsterdam Pharma analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview NewAmsterdam Pharma executives and customers to further validate their buy or sell advice. NewAmsterdam Pharma buy-or-sell recommendation module provides average expert sentiment on the projected NewAmsterdam Pharma target price to derive its highest and lowest estimates based on projected price volatility of 2.9866.
Lowest Forecast
33.67
Highest Forecast
41.07
Target Price
37
Gross Profit is likely to drop to about 42.4 M in 2025. Pretax Profit Margin is likely to drop to -5.57 in 2025. At this time, NewAmsterdam Pharma's Cash And Short Term Investments are comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 907.9 M in 2025, despite the fact that Net Debt is likely to grow to (732.7 M).
  
It's important to approach NewAmsterdam Pharma's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.

NewAmsterdam Pharma Target Price Consensus

NewAmsterdam target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. NewAmsterdam Pharma's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   10  Strong Buy
Strong BuyBuyStrong Buy50.0%Buy50.0%Hold0.0%Sell0.0%Strong Sell0.0%100%
Most NewAmsterdam analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand NewAmsterdam stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of NewAmsterdam Pharma, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

NewAmsterdam Pharma Target Price Projection

NewAmsterdam Pharma's current and average target prices are 23.87 and 37.00, respectively. The current price of NewAmsterdam Pharma is the price at which NewAmsterdam Pharma is currently trading. On the other hand, NewAmsterdam Pharma's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

NewAmsterdam Pharma Market Quote on 22nd of March 2025

Low Price23.6Odds
High Price24.2Odds

23.87

Target Price

Analyst Consensus On NewAmsterdam Pharma Target Price

Low Estimate33.67Odds
High Estimate41.07Odds

37.0

Historical Lowest Forecast  33.67 Target Price  37.0 Highest Forecast  41.07
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on NewAmsterdam Pharma and the information provided on this page.

NewAmsterdam Pharma Analyst Ratings

NewAmsterdam Pharma's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about NewAmsterdam Pharma stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of NewAmsterdam Pharma's financials, market performance, and future outlook by experienced professionals. NewAmsterdam Pharma's historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

JavaScript chart by amCharts 3.21.155.05.05.05.05.05.04.05.00.00.00.00.00.00.00.00.00.00.00.00.0Three Month AgoTwo Month AgoOne Month AgoCurrent 12345
JavaScript chart by amCharts 3.21.15Strong Buy Buy Hold Sell Strong Sell

Average Consensus Estimates

JavaScript chart by amCharts 3.21.15Three Month AgoTwo Months AgoOne Month AgoCurrentStrong SellSellHoldBuyStrong Buy
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize NewAmsterdam Pharma price targets

NewAmsterdam Pharma's stock target price is an estimate of its future price, usually made by analysts. Using NewAmsterdam Pharma's target price to determine if it is a suitable investment can be done through the following steps:
  • Look at NewAmsterdam Pharma's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if NewAmsterdam Pharma's stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional NewAmsterdam Pharma Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of NewAmsterdam Pharma is a key component of NewAmsterdam Pharma valuation and have some predictive power on the future returns of a NewAmsterdam Pharma.
Hype
Prediction
LowEstimatedHigh
20.8023.7926.78
Details
Intrinsic
Valuation
LowRealHigh
21.4828.1031.09
Details
Naive
Forecast
LowNextHigh
19.7222.7025.69
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.52-0.44-0.36
Details

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Business Services Idea
Business Services
Invested few shares
Hedge Favorites Idea
Hedge Favorites
Invested over 60 shares
Corona Opportunity Idea
Corona Opportunity
Invested few shares
Investor Favorites Idea
Investor Favorites
Invested over 300 shares
Cash Cows Idea
Cash Cows
Invested few shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested few shares
Momentum Idea
Momentum
Invested over 60 shares
Manufacturing Idea
Manufacturing
Invested over 30 shares
Driverless Cars Idea
Driverless Cars
Invested over 300 shares
ESG Investing Idea
ESG Investing
Invested few shares
Banking Idea
Banking
Invested over 40 shares
Video Games Idea
Video Games
Invested few shares
Automobiles and Trucks Idea
Automobiles and Trucks
Invested over 300 shares

Additional Tools for NewAmsterdam Stock Analysis

When running NewAmsterdam Pharma's price analysis, check to measure NewAmsterdam Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewAmsterdam Pharma is operating at the current time. Most of NewAmsterdam Pharma's value examination focuses on studying past and present price action to predict the probability of NewAmsterdam Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewAmsterdam Pharma's price. Additionally, you may evaluate how the addition of NewAmsterdam Pharma to your portfolios can decrease your overall portfolio volatility.

Trending Assets

RZLT
Rezolute
3.05  -0.04  -1.29 
PEPG
PepGen
1.77  -0.12  -6.35 
GLUE
Monte Rosa Therapeutics
5.80  -1.26  -17.85 
CYT
Cyteir Therapeutics
0.00  0.00  0.00